110 related articles for article (PubMed ID: 3468909)
1. Reduction of gentamicin nephrotoxicity by the concomitant administration of poly-l-aspartic acid and poly-l-asparagine in rats.
Beauchamp D; Laurent G; Maldague P; Tulkens PM
Arch Toxicol Suppl; 1986; 9():306-9. PubMed ID: 3468909
[TBL] [Abstract][Full Text] [Related]
2. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
Beauchamp D; Laurent G; Maldague P; Abid S; Kishore BK; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):858-66. PubMed ID: 2243354
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
Kishore BK; Lambricht P; Laurent G; Maldague P; Wagner R; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):875-85. PubMed ID: 1700819
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355
[TBL] [Abstract][Full Text] [Related]
5. Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats.
Kishore BK; Ibrahim S; Lambricht P; Laurent G; Maldague P; Tulkens PM
J Pharmacol Exp Ther; 1992 Jul; 262(1):424-32. PubMed ID: 1378098
[TBL] [Abstract][Full Text] [Related]
6. Calcium supplementation and thyroid hormone protect against gentamicin-induced inhibition of proximal tubular Na+,K(+)-ATPase activity and other renal functional changes.
Fukuda Y; Eklöf AC; Malmborg AS; Aperia A
Acta Physiol Scand; 1992 Jun; 145(2):93-8. PubMed ID: 1322021
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of gentamicin nephrotoxicity in rats and the protective effect of zinc-induced metallothionein synthesis.
Du XH; Yang CL
Nephrol Dial Transplant; 1994; 9 Suppl 4():135-40. PubMed ID: 7800247
[TBL] [Abstract][Full Text] [Related]
8. Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats.
Giuliano RA; Paulus GJ; Verpooten GA; Pattyn VM; Pollet DE; Nouwen EJ; Laurent G; Carlier MB; Maldague P; Tulkens PM
Kidney Int; 1984 Dec; 26(6):838-47. PubMed ID: 6533395
[TBL] [Abstract][Full Text] [Related]
9. Influence of hydrocortisone on gentamicin-induced nephrotoxicity in rats.
Beauchamp D; Pettigrew M
Antimicrob Agents Chemother; 1988 Jul; 32(7):992-6. PubMed ID: 3190200
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of gentamicin nephrotoxicity in the rat by infusion of aprotinin.
Morin NJ; Frau A; Nonclercq D; Toubeau G; Zanen J; Heuson-Stiennon JA; Bergeron MG; Beauchamp D; Laurent G
Exp Mol Pathol; 1994 Jun; 60(3):197-213. PubMed ID: 7525340
[TBL] [Abstract][Full Text] [Related]
11. Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity.
Swan SK; Kohlhepp SJ; Kohnen PW; Gilbert DN; Bennett WM
Antimicrob Agents Chemother; 1991 Dec; 35(12):2591-5. PubMed ID: 1810193
[TBL] [Abstract][Full Text] [Related]
12. Co-oxydextran as a protectant against gentamicin-induced renal lysosomal phospholipidosis and focal tubular necrosis. Perspectives and limitations.
Kishore BK; Van Schepdael A; Laurent G; Lambricht P; Claes PJ; Piret J; Tulkens PM; Maldague P
Contrib Nephrol; 1993; 101():213-9. PubMed ID: 7682169
[No Abstract] [Full Text] [Related]
13. The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats.
Erdem A; Gündoğan NU; Usubütün A; Kilinç K; Erdem SR; Kara A; Bozkurt A
Nephrol Dial Transplant; 2000 Aug; 15(8):1175-82. PubMed ID: 10910441
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.
Laurent G; Carlier MB; Rollman B; Van Hoof F; Tulkens P
Biochem Pharmacol; 1982 Dec; 31(23):3861-70. PubMed ID: 7159463
[TBL] [Abstract][Full Text] [Related]
15. Tubular injury and regeneration in the rat kidney following acute exposure to gentamicin: a time-course study.
Nonclercq D; Wrona S; Toubeau G; Zanen J; Heuson-Stiennon JA; Schaudies RP; Laurent G
Ren Fail; 1992; 14(4):507-21. PubMed ID: 1462002
[TBL] [Abstract][Full Text] [Related]
16. Features of gentamicin nephrotoxicity and effect of concurrent cephalothin in the rat.
Sugarman A; Brown RS; Silva P; Rosen S
Nephron; 1983; 34(4):239-47. PubMed ID: 6877460
[TBL] [Abstract][Full Text] [Related]
17. Inability of nitrendipine to protect against gentamicin nephrotoxicity in the rat.
Kacew S
Biomed Environ Sci; 1989 Jun; 2(2):160-6. PubMed ID: 2556158
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides.
Williams PD; Hottendorf GH; Bennett DB
J Pharmacol Exp Ther; 1986 Jun; 237(3):919-25. PubMed ID: 3754895
[TBL] [Abstract][Full Text] [Related]
19. A 2'guanidyl derivative of gentamicin (S86451) with reduced nephrotoxicity studies at low and medium dose levels in the rat.
Maldague P; Laurent G; Carlier MB; Tulkens P
Arch Toxicol Suppl; 1984; 7():455-8. PubMed ID: 6596014
[TBL] [Abstract][Full Text] [Related]
20. Failure of inhibition of lipid peroxidation by vitamin E to protect against gentamicin nephrotoxicity in the rat.
Ramsammy LS; Josepovitz C; Ling KY; Lane BP; Kaloyanides GJ
Biochem Pharmacol; 1987 Jul; 36(13):2125-32. PubMed ID: 3111476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
